image
Healthcare - Biotechnology - NASDAQ - US
$ 1.04
-2.8 %
$ 3.36 M
Market Cap
-0.31
P/E
CASH FLOW STATEMENT
-8.01 M OPERATING CASH FLOW
-30.40%
2.96 M INVESTING CASH FLOW
186.01%
0 FINANCING CASH FLOW
0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Artelo Biosciences, Inc.
image
Net Income -10.1 M
Depreciation & Amortization 2 K
Capital Expenditures 0
Stock-Based Compensation 2.46 M
Change in Working Capital -172 K
Others -406 K
Free Cash Flow -8.01 M

Cash Flow

Millions
Dec-2022 Aug-2021 Aug-2020 Aug-2019 Aug-2018 Aug-2017 Aug-2016 Aug-2015 Aug-2014
OPERATING CASH FLOW
Net Income (10.1) (7.4) (4.7) (2.2) (2.3) (0.2) 29.7 K 15.2 K 15.3 K
Depreciation & Amortization 0 0 500 510 282 600 0 0 0
Deferred Income Tax 0 0 0 (1.0) 0 600 0 0 0
Stock Based Compensation 2.5 1.5 0.4 0.4 0.3 3.33 K 0 0 0
Other Operating Activities (0.2) 7 K 29.5 K 100 K 0 600 0 0 14.7 K
Change in Working Capital (0.2) (0.2) 41.3 K (0.1) 0.4 14.1 K 11.2 K 1.74 K 14.7 K
Cash From Operations (8.0) (6.1) (4.3) (2.8) (1.6) (0.2) 18.5 K 13.5 K 15.3 K
INVESTING CASH FLOW
Capital Expenditures 0 0 0 (1.5) 845 0 0 0 0
Other Items 3.0 (3.4) 0 0 0 0 0 0 0
Cash From Investing Activities 3.0 (3.4) 0 (1.5) 845 0 0 0 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 108 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 6.0 3.15 K 1.05 K 1.84 K 42.7 K 5.05 K 0 0
Cash From Financing Activities 0 14.1 2.0 8.4 1.4 0.8 5.05 K 15.8 K 30 K
CHANGE IN CASH
Net Change In Cash (5.3) 4.5 (2.3) 4.1 (0.2) 0.6 13.4 K 2.3 K 14.7 K
FREE CASH FLOW
Free Cash Flow (8.0) (6.1) (4.3) (4.3) (1.6) (0.2) 18.5 K 13.5 K 15.3 K